Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Zaanan

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
United European Gastroenterology Journal|March 28, 2020
Small bowel polyp resection using device-assisted enteroscopy in Peutz-Jeghers Syndrome: Results of a specialised tertiary care centreG Perrod, E Samaha, E Perez-Cuadrado-Robles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2009
Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatinA Zaanan, P Cuilliere-Dartigues, A Guilloux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2010
Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO studyA Zaanan, L Costes, M Gauthier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2019
Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studiesJ Taieb, Q Shi, L Pederson, et al.
ESMO Open|June 27, 2021
Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS studyJ Tabernero, K Shitara, A Zaanan, et al.
British Journal of Cancer|November 8, 2013
Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic studyT Aparicio, M Svrcek, A Zaanan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2014
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial datasetH Blons, J F Emile, K Le Malicot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2016
Adjuvant FOLFOX +/- cetuximab in full RAS and BRAF wildtype stage III colon cancer patientsJ Taieb, R Balogoun, K Le Malicot, et al.
European Journal of Cancer (Oxford, England : 1990)|April 13, 2015
Predictors of disease-free survival in colorectal cancer with microsatellite instability: An AGEO multicentre studyD Tougeron, G Sickersen, G Mouillet, et al.
ESMO Open|May 13, 2025
Regorafenib combined with irinotecan as second-line treatment in metastatic gastro-oesophageal adenocarcinomas: results of PRODIGE 58-UCGI35-REGIRI Unicancer randomised phase II studyE Samalin, L Evesque, A Turpin, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
United European Gastroenterology Journal|March 28, 2020
Small bowel polyp resection using device-assisted enteroscopy in Peutz-Jeghers Syndrome: Results of a specialised tertiary care centreG Perrod, E Samaha, E Perez-Cuadrado-Robles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2009
Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatinA Zaanan, P Cuilliere-Dartigues, A Guilloux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2010
Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO studyA Zaanan, L Costes, M Gauthier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2019
Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studiesJ Taieb, Q Shi, L Pederson, et al.
ESMO Open|June 27, 2021
Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS studyJ Tabernero, K Shitara, A Zaanan, et al.
British Journal of Cancer|November 8, 2013
Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic studyT Aparicio, M Svrcek, A Zaanan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2014
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial datasetH Blons, J F Emile, K Le Malicot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2016
Adjuvant FOLFOX +/- cetuximab in full RAS and BRAF wildtype stage III colon cancer patientsJ Taieb, R Balogoun, K Le Malicot, et al.
European Journal of Cancer (Oxford, England : 1990)|April 13, 2015
Predictors of disease-free survival in colorectal cancer with microsatellite instability: An AGEO multicentre studyD Tougeron, G Sickersen, G Mouillet, et al.
ESMO Open|May 13, 2025
Regorafenib combined with irinotecan as second-line treatment in metastatic gastro-oesophageal adenocarcinomas: results of PRODIGE 58-UCGI35-REGIRI Unicancer randomised phase II studyE Samalin, L Evesque, A Turpin, et al.
Pageof 3